APA (7th ed.) Citation

SW, S., J, J., & EA, H. (2022). Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply. JAMA, 327(15), 1506. https://doi.org/10.1001/jama.2022.2938

Chicago Style (17th ed.) Citation

SW, Syversen, Jahnsen J, and Haavardsholm EA. "Therapeutic Drug Monitoring Vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply." JAMA 327, no. 15 (2022): 1506. https://doi.org/10.1001/jama.2022.2938.

MLA (9th ed.) Citation

SW, Syversen, et al. "Therapeutic Drug Monitoring Vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply." JAMA, vol. 327, no. 15, 2022, p. 1506, https://doi.org/10.1001/jama.2022.2938.